Global Dog Dewormers Market Size study, By Route of Administration (Topical, Oral), By Distribution Channel (Veterinary Clinics, Retail/Pet Stores, E-Commerce), and Regional Forecasts 2022-2028

Global Dog Dewormers Market Size study, By Route of Administration (Topical, Oral), By Distribution Channel (Veterinary Clinics, Retail/Pet Stores, E-Commerce), and Regional Forecasts 2022-2028Global Dog Dewormers Market is valued at approximately USDXX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2028. Dog Dewormers is an anthelmintic drug that is used to kill the parasites present in the dog such as heartworms, hookworms, roundworms, tapeworms, and others. The rising canine population along with their ownership, increasing incidences of worm infections among dogs, coupled with the growing spending on dogs are several key factors fostering the market demand across the globe. For instance, according to the National Pet Owners Survey (2019-20) conducted by the American Pet Products Association (APPA), more than 85 million households in the United States had one or more pets, of which 63.4 million households own dogs as pets, this, in turn, contributes as 74.6% of the country's total pet-owning households. Accordingly, the rising inclination toward canine adoption among the population is bolstering the market demand, which drives market growth in the impending years. However, the execution of stringent government regulations and several side-effects associated with dewormers impede the growth of the market over the forecast period of 2022-2028. Also, the rising investment in R&D activities and development of new as well as existing products and the growing availability of well-established veterinary care infrastructure facilities are anticipated to act as catalyzing factors for the market demand during the forecast period.

The key regions considered for the global Dog Dewormers Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the growing number of veterinarians and increasing expenditure on dogs. Whereas, Europe is anticipated to exhibit the highest CAGR over the forecast period 2022-2028. Factors such as the growing prevalence of parasitic infections among dogs, as well as rise in the number of veterinary hospitals and clinics, would create lucrative growth prospects for the Dog Dewormers Market across the European region.

Major market players included in this report are:

First Priority, Inc.
Elanco
Durvet Animal Health Products
Bayer AG,
Intervet Inc.
Zoetis
Manna Pro Products LLC
Virbac
Jeffers
Sava Healthcare Limited
Merck & Co., Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Route of Administration:
Topical
Oral
By Distribution Channel:
Veterinary Clinics
Retail/Pet Stores
E-Commerce
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028

Target Audience of the Global Dog Dewormers Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Companies Mentioned

First Priority, Inc.
Elanco
Durvet Animal Health Products
Bayer AG,
Intervet Inc.
Zoetis
Manna Pro Products LLC
Virbac
Jeffers
Sava Healthcare Limited
Merck & Co., Inc.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.